A European Evidence-Based Guideline for the Prevention of Type 2 Diabetes

Европейское руководство, основанное на доказательных данных, по профилактике сахарного диабета 2 типа
Michael Roden, Ram Weiss, Martin McKee, Markku Peltonen, Jaakko Tuomilehto, Konstantinos Makrilakis, Jaana Lindström, Michael Stephen Hall, Ala’a Alkerwi, Stavros Liatis, Jussi K. Huttunen, Hans Hauner, Nebojsa M. Lalic, Aleksandra Jotić, Katarina S. Lalic, Katarzyna Kissimova‐Skarbek, Peter E. H. Schwarz, Ulrike Rothe, Bernhard Kulzer, Bernhard Paulweber, Andreas Stadlmayr, Charles Abraham, Wendy Hardeman, S. Karadeniz, Andreas F. H. Pfeiffer, Julia Szendroedi, Noël Christopher Barengo, Claudia Huber, Timo Saaristo, Colin James Greaves, Bernd Stratmann, Džilda Veličkienė, Tsvetalina I. Tankova, Thomas Reinehr, Emmanuel Cosson, Paul Elie Valensi, Aleksandra Gilis‐Januszewska, C. Robinson, Lyudmyla Kedenko, Norbert Hermanns, Philip Hugh Evans, Pia Pajunen, Young Lee-Barkey, Daniel Tolks, K. Edwin Sheppard, Kate Charlesworth, A.-M. Felton, A. Rissanen, M. Paulweber, Nikolaos L. Katsilambros, Zdravko Asenov Kamenov, P. Djordevic, Vesna S. Dimitrijevic-Sreckovic, Ulrich Hühmer, Sabine Puhl, Tania Acosta, Marcia Adler, R Barengo, José Manuel Boavida, Vladimir G. Christov, B Claussen, Xavier Cos, S. Deceukelier, Predrag Djordjević, María Isabel Fischer, Rafael Gabriel-Sánchez, Margalit Goldfracht, Joseph E. Gomez, Ulrich Handke, J. Herbst, L. Herrebrugh, Mykola D. Khalangot, D. Köhler, V. Kopp, Peter Kronsbein, D. Kyne‐Grzebalski, R�diger Landgraf, C. McIntosh, Ana Cristina Mesquita, Dana Misiņa, F. Muylle, A. Neumann, A. Paiva, Luz Perrenoud, Auli Pölönen, Falcão Raposo, J. Scholl, S. Spiers, T. Stemper, Z Szybiński, Victoria Telle Hjellset, Gavin Terry, F. Toti, A. Undeutsch, Cristina Valadas, Paulina W.A. Vermunt, Johan Wens, T. Yilmaz
2010-04-01

impaired glucose tolerancelifestyle interventionoral glucose tolerance testingrisk screeningtype 2 diabetes prevention
BACKGROUND: The prevalence and socioeconomic burden of type 2 diabetes (T2DM) and associated co-morbidities are rising worldwide. AIMS: This guideline provides evidence-based recommendations for preventing T2DM. METHODS: A European multidisciplinary consortium systematically reviewed the evidence on the effectiveness of screening and interventions for T2DM prevention using SIGN criteria. RESULTS: Obesity and sedentary lifestyle are the main modifiable risk factors. Age and ethnicity are non-modifiable risk factors. Case-finding should follow a step-wise procedure using risk questionnaires and oral glucose tolerance testing. Persons with impaired glucose tolerance and/or fasting glucose are at high-risk and should be prioritized for intensive intervention. Interventions supporting lifestyle changes delay the onset of T2DM in high-risk adults (number-needed-to-treat: 6.4 over 1.8-4.6 years). These should be supported by inter-sectoral strategies that create health promoting environments. Sustained body weight reduction by >or= 5 % lowers risk. Currently metformin, acarbose and orlistat can be considered as second-line prevention options. The population approach should use organized measures to raise awareness and change lifestyle with specific approaches for adolescents, minorities and disadvantaged people. Interventions promoting lifestyle changes are more effective if they target both diet and physical activity, mobilize social support, involve the planned use of established behaviour change techniques, and provide frequent contacts. Cost-effectiveness analysis should take a societal perspective. CONCLUSIONS: Prevention using lifestyle modifications in high-risk individuals is cost-effective and should be embedded in evaluated models of care. Effective prevention plans are predicated upon sustained government initiatives comprising advocacy, community support, fiscal and legislative changes, private sector engagement and continuous media communication.
1
Effective prevention requires cost-effective, evaluated models of care supported by government, community, fiscal, legislative, private-sector, and media initiatives.
2
Lifestyle interventions delay type 2 diabetes onset in high-risk adults, with a number-needed-to-treat of 6.4 over 1.8–4.6 years.
3
Lifestyle programs are more effective when combining diet and physical activity with social support, behavior-change techniques, and frequent contacts.
4
Obesity and sedentary lifestyle are the main modifiable risk factors for type 2 diabetes, while age and ethnicity are non-modifiable risks.
5
People with impaired glucose tolerance and/or fasting glucose should receive priority for intensive preventive interventions.
6
Stepwise case-finding should combine risk questionnaires with oral glucose tolerance testing to identify individuals requiring prevention.
7
Sustained body-weight reduction of at least 5% lowers diabetes risk; metformin, acarbose, and orlistat may be considered as second-line options.

Type 2 diabetes prevention in high-risk adults and populations

Evidence-based screening and lifestyle, pharmacological, and population-level interventions for delaying or preventing type 2 diabetes onset

Publication Details
Publication Date
2010-04-01
Journal
Publisher
ISSN
Cited by
469
Access Type
Author Information
Authors
Michael Roden
Ram Weiss
Martin McKee
Markku Peltonen
Jaakko Tuomilehto
Konstantinos Makrilakis
Jaana Lindström
Michael Stephen Hall
Ala’a Alkerwi
Stavros Liatis
Jussi K. Huttunen
Hans Hauner
Nebojsa M. Lalic
Aleksandra Jotić
Katarina S. Lalic
Katarzyna Kissimova‐Skarbek
Peter E. H. Schwarz
Ulrike Rothe
Bernhard Kulzer
Bernhard Paulweber
Andreas Stadlmayr
Charles Abraham
Wendy Hardeman
S. Karadeniz
Andreas F. H. Pfeiffer
Julia Szendroedi
Noël Christopher Barengo
Claudia Huber
Timo Saaristo
Colin James Greaves
Bernd Stratmann
Džilda Veličkienė
Tsvetalina I. Tankova
Thomas Reinehr
Emmanuel Cosson
Paul Elie Valensi
Aleksandra Gilis‐Januszewska
C. Robinson
Lyudmyla Kedenko
Norbert Hermanns
Philip Hugh Evans
Pia Pajunen
Young Lee-Barkey
Daniel Tolks
K. Edwin Sheppard
Kate Charlesworth
A.-M. Felton
A. Rissanen
M. Paulweber
Nikolaos L. Katsilambros
Zdravko Asenov Kamenov
P. Djordevic
Vesna S. Dimitrijevic-Sreckovic
Ulrich Hühmer
Sabine Puhl
Tania Acosta
Marcia Adler
R Barengo
José Manuel Boavida
Vladimir G. Christov
B Claussen
Xavier Cos
S. Deceukelier
Predrag Djordjević
María Isabel Fischer
Rafael Gabriel-Sánchez
Margalit Goldfracht
Joseph E. Gomez
Ulrich Handke
J. Herbst
L. Herrebrugh
Mykola D. Khalangot
D. Köhler
V. Kopp
Peter Kronsbein
D. Kyne‐Grzebalski
R�diger Landgraf
C. McIntosh
Ana Cristina Mesquita
Dana Misiņa
F. Muylle
A. Neumann
A. Paiva
Luz Perrenoud
Auli Pölönen
Falcão Raposo
J. Scholl
S. Spiers
T. Stemper
Z Szybiński
Victoria Telle Hjellset
Gavin Terry
F. Toti
A. Undeutsch
Cristina Valadas
Paulina W.A. Vermunt
Johan Wens
T. Yilmaz
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%